|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
14 June 2021 |
|
Main ID: |
JPRN-UMIN000044518 |
|
Date of registration:
|
13/06/2021 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
A Study on Targeting the Rate of Change of Muscle-Adipose Tissue for the Prevention of Cardiovascular Disease
|
|
Scientific title:
|
A Study on Targeting the Rate of Change of Muscle-Adipose Tissue for the Prevention of Cardiovascular Disease - A Study on Targeting the Rate of Change of Muscle-Adipose Tissue for the Prevention of Cardiovascular Disease |
|
Date of first enrolment:
|
2019/10/01 |
|
Target sample size:
|
1000 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050861 |
|
Study type:
|
Observational |
|
Study design:
|
Not selected Not selected
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
yutaka
kimura |
|
Address:
|
2-5-1 Shinmachi, Hirakata, Osaka
Japan |
|
Telephone:
|
072-804-0101 |
|
Email:
|
kimuray@takii.kmu.ac.jp |
|
Affiliation:
|
Kansai Medical University Health Science Center |
|
|
Name:
|
Satoshi
Kurose |
|
Address:
|
2-5-1 Shinmachi, Hirakata, Osaka
573-1010
Japan |
|
Telephone:
|
072-804-0101 |
|
Email:
|
kurosesa@hirakata.kmu.ac.jp |
|
Affiliation:
|
Kansai Medical University Health Science Center |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Exclusion criteria
Patients who violate any of the following will not be included in this study
(1) Patients with severe hepatic or renal dysfunction
(2) Pregnant or lactating women
3) Patients with a history of wasting disease or condition causing extreme weight loss (severe infection, invasive surgery, malignancy, severe trauma, hyperthyroidism, etc.) within the past 6 months
(4) Patients after implantation of pacemakers and implantable defibrillators
5) Patients with psychiatric disorders that are difficult to manage
(6) Patients who are unable to obtain written consent or who do not understand the outline and purpose of the research
(7) Patients who are judged by the principal investigator to be inappropriate as research subjects.
Age minimum:
20years-old
Age maximum:
120years-old
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
obesity
Sarcopenia
|
|
Primary Outcome(s)
|
|
The primary endpoints of this study will be changes in skeletal muscle mass and body fat mass.
|
|
Secondary Outcome(s)
|
|
Secondary endpoints will be body weight, blood pressure, glycolipid metabolic factors, adipokines, myokines, abdominal fat, arterial stiffness, physical fitness and physical activity, diet-related factors, and psychological indicators.
|
|
Source(s) of Monetary Support
|
|
Japan Society for the Promotion of Science
|
|
Ethics review
|
Status: YES
Approval date: 01/10/2019
Contact:
rinriirb@hirakata.kmu.ac.jp
Kansai Medical University Center for Ethical Review
072-804-2440
rinriirb@hirakata.kmu.ac.jp
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
31/03/2022 |
|
URL:
|
|
|
|